WA-SPIE-PHOTONICS-WEST
Earlier this evening, following a festive reception during SPIE Photonics West, SPIE, the international society for optics and photonics , and Photonics Media recognized the top optics and photonics products on the market with their industry-focused Prism Awards.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220126005964/en/
The 14th annual ceremony showcased a dynamic range of companies — from Luxexcel, PlenOptika, and Lumotive, to SWIR, LightPath Technologies, and ColdQuanta — applying innovative and creative solutions to critical problems in areas such as augmented and virtual reality, biomedical devices, autonomous vehicles, quantum, and industrial lasers. In addition, the 2021 Prism Award winners of last year’s virtual ceremony were recognized in person at the beginning of the program.
Each year, the Prism Awards reflect the latest exciting developments, exponential growth, and rich technical innovations across photonics and photonics-enabled industries. For consideration in this year's awards, SPIE received 120 applications from 18 countries.
Finalists and winners were selected by a panel of international judges who leveraged the knowledge and acumen of leaders from across the technology commercialization and funding sectors. The distinguished judges’ roster included MKS Instruments’ Marc D. Himel , the FDA’s Zane Arp , Femto Blanc’s Uri Abrams , iFocus’ Adi Diner , Berkeley Catalyst Fund’s Laura Smoliar , Engender Technologies’ Cather Simpson , Luminate Accelerator’s Sujatha Ramanujan , Notal Vision’s Nishant Mohan , Teledyne Princeton Instruments’ Jason McClure , and Chromacity’s Shahida Imani .
"We are particularly delighted to be celebrating our Prism Award winners in person this year,” said SPIE CEO Kent Rochford . "These companies with their scientists and engineers — and I am including the award finalists as well — are ensuring that key technologies and products are reaching, energizing, and continually growing the photonics market. Their critical, innovative work is impacting lives across the globe.”
"Each year, the Prism Awards singles out the very brightest innovations in a highly innovative industry and, despite a global pandemic, supply chain issues, and other challenges over the past year, the 2022 winners still found a way to advance the field of photonics in important and remarkable ways,” said President and CEO of Photonics Media Tom Laurin . “We extend our congratulations to each of this year’s winners, who deserve our industry's recognition for their advancements in transportation, biomedicine, research, sensing, and quantum technology."
Below is the complete list of the award categories and the winners:
- Augmented & Virtual Reality: Luxexcel
- Autonomous Vehicles: Lumotive
- Better Sensing: SWIR Vision Systems
- Biomedical Devices: PlenOptika
- Displays: BRELYON
- Industrial Lasers: Civan Lasers
- Manufacturing & Test: LightPath Technologies
- Quantum: ColdQuanta
- Scientific Lasers: Stuttgart Instruments
- Software: Zemax
To find out more about the Prism Awards, please visit our website .
About Photonics Media
Photonics Media publishes print and digital business-to-business magazines, buyers' guides, websites, e-newsletters, webinars, virtual conferences, and podcasts for individuals working with light-based technologies in the photonics industry. A pioneering publisher in the discipline of photonics, Photonics Media has built a large global audience comprising academics and researchers, manufacturers, and end-users. Over the past six decades, the company has fostered a tradition of innovation that has defined the industry. As its publications grow — following the technology into an ever-widening range of applications — the company adheres to a philosophy of editorial quality and integrity, maintaining an international reputation for leadership in photonics. www.photonics.com .
About SPIE
SPIE, the international society for optics and photonics, brings engineers, scientists, students, and business professionals together to advance light-based science and technology. The Society, founded in 1955, connects and engages with our global constituency through industry-leading conferences and exhibitions; publications of conference proceedings, books, and journals in the SPIE Digital Library; and career-building opportunities. Over the past five years, SPIE has contributed more than $22 million to the international optics community through our advocacy and support, including scholarships, educational resources, travel grants, endowed gifts, and public-policy development. www.spie.org .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220126005964/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
The Blind Sailor Takes the Stage at WEF: "HIRO’s CHOICE" Project to Set Sail13.1.2026 05:00:00 CET | Press release
A Solo, Non-Stop Crossing of the Pacific Ocean “Blind Sailor Single-Handed Pacific Crossing Project 2027” is a world-first initiative in which Mitsuhiro Iwamoto, a completely blind Japanese yachtsman (blind sailor) based in San Diego, will attempt a solo, non-stop trans-Pacific crossing in the spring of 2027. Sailing a 28-foot yacht single-handedly, he aims to cross the Pacific Ocean from San Diego on the U.S. West Coast to Amakusa, Kumamoto Prefecture, Japan, without making port. Iwamoto will speak about this project at the World Economic Forum Annual Meeting 2026, to be held in January 2026. Project URL: https://hiros-choice.com/ This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260108087321/en/ Hiro Iwamoto / Global Keynote Speaker, First Totally Blind Sailor to Cross the Pacific The message he most wishes to convey at the WEF is the power of choice. He lost his sight at the age of sixteen—a moment when he nearly gave up on
MarkLines Gen-AI Beta Version Released for Automotive Industry13.1.2026 01:00:00 CET | Press release
MarkLines Co., Ltd. (Headquarters: Minato-ku, Tokyo; President & CEO: Makoto Sakai; TYO:3901) announced its launch of the "MarkLines Gen-AI Beta Version," the new feature for B2B users in the automotive industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112383839/en/ "MarkLines Gen-AI Beta Version" can take questions in natural language and instantly give highly reliable, relevant data drawn from MarkLines’ extensive automotive database (Image: MarkLines Co., Ltd.) This AI-powered feature enables users to ask questions in natural language and instantly receive highly reliable, relevant data drawn from MarkLines’ extensive automotive database. Moreover, the system analyzes this information by leveraging the rich content across its platform and delivers clear, concise, text-based insights. By combining trusted data with advanced analytical capabilities through generative AI, this service represents a first-of-its-kind
Australian Defence Force Secures Satellite Communications on SES IS-2212.1.2026 22:30:00 CET | Press release
New agreement for uninterrupted UHF connectivity for Australian Defence Force through 2033, With Options Extending to 2041 Satellite communications solutions provider SES will provide secure uninterrupted satellite communications to the Australian Defence Force (ADF) for a minimum of 16 years thanks to a new extended agreement. The service will be provided via the SES Intelsat 22 satellite and an ultra-high frequency (UHF) military communications payload. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112137182/en/ Assistant Secretary Space Systems Branch, Michael Hunt, formalizes contract negotiations for the through-life support of the IS-22 satellite with Rory Welch, senior vice-president of service delivery at SES Space and Defense. Photos: Corporal Annika Smit Under the renewed arrangement, SES will reposition the IS-22 satellite to a new orbital slot specified by the ADF, continuing a mission that has been the corne
NetApp Appoints Paul Fipps to the Board of Directors12.1.2026 22:05:00 CET | Press release
NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced that Paul Fipps, President of Global Customer Operations at ServiceNow, has joined its Board of Directors. The board now has ten directors, nine of whom are independent, and 50% of whom have been appointed within the last five years. Fipps brings more than 20 years of experience driving technology-enabled growth and customer transformation. At ServiceNow, he currently leads global sales, customer success, partner ecosystems, and field operations. He previously served as EVP of Worldwide Sales at ServiceNow and as President of Under Armour Connected Fitness and Chief Experience Officer at Under Armour, overseeing global direct-to-consumer, connected fitness, and digital experiences. He also previously served on the advisory board of Quantum Metric. Fipps holds a B.S. in Information Systems, an MBA from the University of Baltimore, and is a graduate of The Wharton School’s Advanced Management Program. “P
FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor12.1.2026 20:00:00 CET | Press release
Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, announced today that the U.S. Food and Drug Administration (FDA) has accepted the company’s new drug application (NDA) for pimicotinib as a systemic treatment for patients with tenosynovial giant cell tumor (TGCT). The application is based on the primary results and longer-term follow-up of the global Phase 3 MANEUVER study, which demonstrated deep and durable tumor responses and meaningful improvements in clinical outcomes with pimicotinib. “With pimicotinib, we have an opportunity to significantly advance care for people living with TGCT, a painful and debilitating disease that has few effective and well-tolerated treatment options beyond surgery,” said David Weinreich, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck. “Based on clinical trial results showing not only a reduction in tumor burden, but also the ability to help alleviate symptoms like pain an
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom